A detailed history of Bessemer Group Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 525 shares of INVA stock, worth $9,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
525
Previous 492 6.71%
Holding current value
$9,334
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$16.33 - $20.04 $538 - $661
33 Added 6.71%
525 $10,000
Q2 2024

Aug 13, 2024

SELL
$14.4 - $16.4 $24,753 - $28,191
-1,719 Reduced 77.75%
492 $8,000
Q1 2024

May 13, 2024

BUY
$14.56 - $16.78 $24,766 - $28,542
1,701 Added 333.53%
2,211 $33,000
Q3 2023

Nov 13, 2023

BUY
$12.37 - $13.89 $964 - $1,083
78 Added 18.06%
510 $7,000
Q2 2023

Aug 10, 2023

BUY
$11.39 - $13.72 $1,070 - $1,289
94 Added 27.81%
432 $5,000
Q1 2023

May 10, 2023

BUY
$10.73 - $13.6 $515 - $652
48 Added 16.55%
338 $4,000
Q3 2022

Nov 09, 2022

BUY
$11.61 - $15.22 $278 - $365
24 Added 9.02%
290 $3,000
Q1 2022

May 12, 2022

SELL
$15.39 - $20.25 $169 - $222
-11 Reduced 3.97%
266 $5,000
Q4 2021

Jan 27, 2022

BUY
$15.91 - $18.72 $4,407 - $5,185
277 New
277 $5,000
Q3 2020

Nov 12, 2020

SELL
$10.33 - $14.49 $583,645 - $818,685
-56,500 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$8.11 - $15.23 $458,214 - $860,495
56,500 New
56,500 $664,000
Q1 2019

May 13, 2019

SELL
$13.69 - $20.06 $601,251 - $881,015
-43,919 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$13.96 - $18.26 $595,826 - $779,355
42,681 Added 3447.58%
43,919 $767,000
Q3 2018

Nov 06, 2018

BUY
$13.63 - $15.7 $16,873 - $19,436
1,238 New
1,238 $19,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.